Author

Aude G. Chapuis

University of WashingtonORCID 0000-0002-9574-5448Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Assay:proteomics· 2 Research Focus:cancer & tumor microenvironment· 1 Approach:deep learning· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Charanjit SinghiD· 1 shared Chuyi WangiD· 1 shared Clara McCurdyiD· 1 shared Donny Gun· 1 shared Emily Y. Chen· 1 shared Gerardo Javier· 1 shared Ioanna Panagi· 1 shared Jakob BakhtiariiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

Charanjit SinghORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BioengineeringNature Biomedical EngineeringPeer-reviewedOct 23, 2025

Collagen-binding IL-12 expressing STEAP1 CAR-T cells reduce toxicity and eradicate mouse prostate cancer in combination with checkpoint inhibitors

Koichi Sasaki, Vipul Bhatia, Yuta Asano…·Jun Ishihara

17 citationstop 2%

mouseproteomics

𝕏 PostBluesky

ImmunologybioRxivPreprintSep 18, 2024

Overcoming immune evasion from post-translational modification of a mutant KRAS epitope to achieve TCR-T cell-mediated antitumor activity

Jihoon William Lee, Emily Y. Chen, Taylor Hu…·Philip D. Greenberg

Tumor cell methylation of KRASG12V epitope in HLA-A2 permits immune evasion, and new TCRs were generated to overcome this with engineered cell therapy.

DOI 10.1101/2024.09.18.612965

humanproteomics

𝕏 PostBluesky